Close Menu
DDmalar
    Facebook X (Twitter) Instagram
    Trending
    • FDA Study Finds Liver Risks from Even Low CBD Doses
    • CDC Lifts Bird Flu Alert as Scientists Caution Against Fall Spike
    • New Malaria Treatment for Infants Approved for the First Time
    • Measles Cases Hit Highest Levels Since U.S. Declared Disease Eliminated
    • 10 Best Foods Packed with Biotin
    • This Upgrade Will Make the Nintendo Switch 2 More Expensive
    • Call of Duty: Warzone Rolls Out July 2025 Update
    • Jean Grey’s ‘Chaos Phoenix’ Skin Debuts in Marvel Rivals Gameplay Reveal
    Facebook X (Twitter) Instagram LinkedIn VKontakte
    DDmalar
    • Home
    • Technology
    • Business
    • Entertainment
    • Fashion
    • Gaming
    • Health
    DDmalar
    You are at:Home»Health»FDA Study Finds Liver Risks from Even Low CBD Doses
    Health

    FDA Study Finds Liver Risks from Even Low CBD Doses

    Gunjan NagarBy Gunjan NagarJuly 21, 2025No Comments7 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    FDA Study Finds Liver Risks from Even Low CBD Doses

    In recent years, cannabidiol (CBD) has surged in popularity as a natural remedy for everything from anxiety to chronic pain. With CBD oils, capsules, gummies, and topical products lining the shelves of wellness stores and pharmacies, it’s easy to assume that this cannabis-derived compound is safe—especially since it doesn’t produce the “high” associated with marijuana.

    The findings are significant because they point to potential liver toxicity even at doses commonly used in daily wellness routines. As CBD’s popularity continues to grow, these new insights raise important questions about how safe it truly is, especially when used regularly or alongside other medications.

    The FDA’s findings serve as a timely reminder that “natural” doesn’t always mean risk-free. This article breaks down the latest study, what it means for current CBD users, and how you can make informed decisions about your health.

    More Read: CDC Lifts Bird Flu Alert as Scientists Caution Against Fall Spike

    What Is CBD?

    Cannabidiol (CBD) is one of more than 100 cannabinoids found in the Cannabis sativa plant. Unlike its psychoactive cousin, tetrahydrocannabinol (THC), CBD does not produce a euphoric high. This quality has made it especially appealing to people seeking therapeutic benefits without cognitive impairment.

    CBD is used to relieve:

    • Anxiety and stress
    • Insomnia and other sleep disorders
    • Chronic pain
    • Epileptic seizures (especially with FDA-approved Epidiolex)
    • Inflammation
    • PTSD and depression

    Despite the popularity and wide usage, questions remain about its long-term safety—especially in over-the-counter, non-pharmaceutical-grade products.

    The FDA’s Latest Study: An Overview

    The FDA recently conducted a multi-phase study to evaluate CBD’s impact on liver function. The research involved both animal models and a review of clinical trial data from human use, particularly those involving the CBD-based medication Epidiolex, which is approved to treat rare forms of epilepsy.

    Key Findings:

    Liver Enzyme Elevation: Even at relatively low doses, some users experienced elevated levels of liver enzymes such as ALT (alanine transaminase) and AST (aspartate transaminase), which are early warning signs of liver damage.

    • Accumulation Over Time: Repeated daily use, even of low-dose CBD, appeared to cause cumulative effects in liver tissue, especially when combined with other medications.
    • Individual Sensitivity: Some participants exhibited signs of liver stress at much lower doses than others, suggesting genetic variability and underlying conditions could influence risk.
    • Potential for Drug Interactions: CBD was shown to interfere with cytochrome P450 enzymes in the liver, which are responsible for metabolizing many prescription medications.
    • Doses Evaluated: The FDA evaluated doses as low as 5 mg/kg/day, which is consistent with or even below what many commercial CBD users consume.

    Why Is the Liver So Affected by CBD?

    The liver acts as the body’s detox center. It processes everything from alcohol to prescription drugs to dietary supplements. CBD is metabolized by hepatic enzymes, particularly CYP3A4 and CYP2C19. When CBD interacts with these enzymes, it can either:

    • Slow down the metabolism of other drugs (leading to higher levels in the bloodstream)
    • Speed up their breakdown (potentially making them less effective)
    • Overwork the liver itself, leading to inflammation or injury

    The study revealed that CBD acts as a “pharmacological wildcard”, unpredictably affecting liver function depending on dosage, user age, other medications, and overall health.

    What Does This Mean for the Average CBD User?

    For many people, CBD use may still be relatively safe—especially when used occasionally or under medical supervision. However, the findings raise red flags for daily users, people with pre-existing liver conditions, and those taking other medications.

    Potential Red Flags for Liver Issues Include:

    • Yellowing of the eyes or skin (jaundice)
    • Dark urine
    • Nausea or vomiting
    • Abdominal discomfort
    • Unexplained bruising or bleeding
    • Fatigue

    If you’re experiencing any of these symptoms while using CBD, it’s essential to consult a healthcare provider immediately.

    What About Over-the-Counter CBD?

    One major issue with the booming CBD market is lack of regulation. Many over-the-counter CBD products are:

    • Inaccurately labeled
    • Contaminated with pesticides, heavy metals, or THC
    • Unreliable in dosage strength

    The FDA study highlights the urgent need for stricter quality control, standardized labeling, and more consumer education.

    Even if a product is labeled “low-dose,” that label may not reflect what’s actually inside the bottle.

    Moving Forward: Recommendations from the FDA

    Following the study, the FDA has issued several recommendations for CBD users and industry stakeholders:

    • Limit frequency and duration of CBD use unless medically supervised.
    • Avoid mixing CBD with alcohol or acetaminophen, which also strain the liver.
    • Report any side effects or adverse reactions to the FDA’s MedWatch program.
    • Consult your doctor before starting any CBD regimen, especially if you have liver disease or are taking prescription medications.
    • Watch for upcoming regulatory changes that may require better testing and standardization of products.

    Industry Response

    CBD manufacturers have responded with mixed reactions:

    • Some companies welcomed the findings, pledging to improve testing and transparency.
    • Others questioned the study’s sample size and relevance to the general public.

    In the meantime, reputable companies are voluntarily adding liver health warnings and encouraging users to start with small doses.

    What Can You Do to Stay Safe?

    Here are some proactive steps you can take if you currently use or are considering using CBD:

    Know Your Source

    Only buy from brands that provide third-party lab results (COAs) confirming dosage, purity, and safety.

    Track Your Dose

    Start low—typically 5 to 10 mg—and increase gradually only if needed. Keep a journal of how your body responds.

    Watch for Interactions

    Check with your doctor or pharmacist to ensure CBD won’t interfere with other medications you take.

    Test Your Liver

    If you’re a regular user, ask your doctor for periodic liver enzyme tests to monitor any changes in liver function.

    Use with Purpose

    Don’t use CBD as a “wellness supplement” without a specific goal. Treat it like any therapeutic intervention, not a daily vitamin.

    A Call for More Research

    Despite the risks, CBD holds enormous potential for therapeutic use. What’s needed now is comprehensive, long-term research to guide medical professionals, manufacturers, and consumers.

    Areas needing more study:

    • Effects of long-term low-dose CBD use
    • Impact on elderly individuals and children
    • CBD’s interaction with common medications like blood thinners, antidepressants, and statins
    • Genetic factors that make some people more vulnerable
    • Safe thresholds for daily use

    Frequently Asked Question

    Can CBD actually cause liver damage?

    Yes, according to the FDA study, even low doses of CBD have been linked to elevated liver enzymes—a potential indicator of liver injury. While not everyone is affected, some people may be more vulnerable due to genetics, underlying health conditions, or medication use.

    How much CBD is considered a “low dose”?

    The study examined doses starting at 5 mg/kg/day, which translates to about 350 mg per day for a 70-kg adult. However, effects were seen at even lower doses in some cases, depending on the person’s metabolism and concurrent medication use.

    Is occasional CBD use still safe?

    For most healthy individuals, occasional or short-term use is likely safe. The primary concern is with long-term daily use, especially when combined with other medications or alcohol.

    How can I tell if CBD is affecting my liver?

    Look for early signs like fatigue, nausea, jaundice, or dark urine. You can also ask your doctor to check your liver enzymes through a blood test if you’re using CBD regularly.

    Are certain people more at risk for CBD-related liver issues?

    Yes. People with pre-existing liver disease, those taking medications metabolized by the liver, the elderly, and people with genetic differences in liver enzymes are at greater risk.

    Does the risk apply to topical CBD products?

    Topical CBD (like creams and balms) is less likely to affect the liver since it doesn’t enter the bloodstream in significant amounts. However, products intended for ingestion or sublingual use do pose a risk.

    What’s the FDA doing about this issue?

    The FDA is increasing efforts to regulate CBD products, improve labeling, and encourage further research. It also recommends that users report side effects and consult healthcare providers before using CBD regularly.

    Conclusion

    The FDA’s findings are a crucial reminder that even popular natural remedies come with potential downsides. CBD may help many, but it isn’t risk-free—especially for the liver. If you use CBD, stay informed, read labels carefully, and involve your healthcare provider in any wellness plan. Ultimately, your liver health isn’t something to gamble with. In the world of wellness trends, knowledge remains your best defense.

    Previous ArticleCDC Lifts Bird Flu Alert as Scientists Caution Against Fall Spike
    Gunjan Nagar
    Gunjan Nagar
    • Website

    Gunjan Nagar is the founder and administrator of DDmalar, a platform at the forefront of innovation in precision engineering, smart technology, and intelligent design. With a keen eye for emerging trends and a commitment to excellence, Gunjan leads DDmalar in delivering cutting-edge solutions that empower industries to operate more efficiently and intelligently. His vision drives the company's mission to shape the future through technology-driven excellence.

    Related Posts

    CDC Lifts Bird Flu Alert as Scientists Caution Against Fall Spike

    July 20, 2025

    New Malaria Treatment for Infants Approved for the First Time

    July 20, 2025

    Measles Cases Hit Highest Levels Since U.S. Declared Disease Eliminated

    July 20, 2025
    Leave A Reply Cancel Reply

    Live Search Results
    Recent Posts

    FDA Study Finds Liver Risks from Even Low CBD Doses

    July 21, 2025

    CDC Lifts Bird Flu Alert as Scientists Caution Against Fall Spike

    July 20, 2025

    New Malaria Treatment for Infants Approved for the First Time

    July 20, 2025

    Measles Cases Hit Highest Levels Since U.S. Declared Disease Eliminated

    July 20, 2025

    10 Best Foods Packed with Biotin

    July 20, 2025

    This Upgrade Will Make the Nintendo Switch 2 More Expensive

    July 19, 2025
    About Us

    DDmalar drives innovation through precision engineering, smart technology, intelligent design.

    We build cutting-edge solutions for faster, smarter, efficient industry workflows. From automation to product development, DDmalar shapes future tech with performance, accuracy, impact. #DDmalar

    Facebook X (Twitter) Instagram LinkedIn VKontakte
    Popular Posts

    FDA Study Finds Liver Risks from Even Low CBD Doses

    July 21, 2025

    CDC Lifts Bird Flu Alert as Scientists Caution Against Fall Spike

    July 20, 2025

    New Malaria Treatment for Infants Approved for the First Time

    July 20, 2025
    Contact Us

    Have any questions or need support? Don’t hesitate to get in touch—we’re here to assist you!

    • Email: contact@outreachmedia.io
    • Whatsapp: +92 3055631208
    • Facebook: Outreachmedia
    • Address: 940 S Westwood Blvd, Poplar Bluff, Missouri, United States

    Copyright © 2026 | All Right Reserved | DDmalar

    • About Us
    • Contact Us
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • Write For Us
    • Sitemap

    Type above and press Enter to search. Press Esc to cancel.

    WhatsApp us